Pier 88 Investment Partners’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-134,060
Closed -$505K 120
2025
Q2
$505K Sell
134,060
-95,810
-42% -$377K 0.09% 89
2025
Q1
$1.04M Buy
229,870
+58,980
+35% +$312K 0.2% 49
2024
Q4
$1.21M Buy
170,890
+7,450
+5% +$59.3K 0.24% 47
2024
Q3
$1.33M Buy
163,440
+33,200
+25% +$240K 0.29% 43
2024
Q2
$832K Buy
130,240
+93,190
+252% +$598K 0.19% 64
2024
Q1
$279K Buy
37,050
+7,950
+27% +$72.6K 0.07% 81
2023
Q4
$269K Sell
29,100
-72,370
-71% -$591K 0.07% 78
2023
Q3
$1.03M Buy
101,470
+11,080
+12% +$132K 0.26% 64
2023
Q2
$1.13M Buy
90,390
+35,770
+65% +$426K 0.28% 59
2023
Q1
$637K Buy
+54,620
New +$696K 0.15% 64

Other funds holding HCAT